Proposal for the Best Pharmacovigilance Plan in Japan by comparing Japan Postmarketing Studies to the U.S. Postmarketing Requirements

Proposal for the Best Pharmacovigilance Plan in Japan by comparing Japan Postmarketing Studies to the U.S. Postmarketing Requirements

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Japanese journal of pharmacoepidemiology 2012, Vol.17 (1), p.55-66
Hauptverfasser: KOKAN, Akira, KAI, Yasuhiko, KAGEYAMA, Shigeru, KUBOTA, Kiyoshi, TSUTANI, Kiichiro, NISHI, Toshimichi, MAEDA, Rei, MASADA, Mikio, MIYAKAWA, Kou
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 66
container_issue 1
container_start_page 55
container_title Japanese journal of pharmacoepidemiology
container_volume 17
creator KOKAN, Akira
KAI, Yasuhiko
KAGEYAMA, Shigeru
KUBOTA, Kiyoshi
TSUTANI, Kiichiro
NISHI, Toshimichi
MAEDA, Rei
MASADA, Mikio
MIYAKAWA, Kou
description
doi_str_mv 10.3820/jjpe.17.55
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_3820_jjpe_17_55</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_3820_jjpe_17_55</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1125-d096952a9457ec2bc8126d2311040e21bc399c41b583f77197acf78c422eb2203</originalsourceid><addsrcrecordid>eNpdkN1KwzAcxYMoOOZufIJcC63JP03TXOrwk4HFOfCupFm6Za5NTTJhD-B72-muvDo_DofD4SB0SUnKCiDXm01vUipSzk_QiBYFJEKS99OBWQYJyTJ-jiYh2JoQABA5oSP0XXrXu6C2uHEex7XBtyZEXK6Vb5V2X3Zlt6rTBpeDYNvhZ9UPUO-xdm2vvO1WR6t0IbbKf5h48OZxt7Qm4Oh-SxfpPP2XeDWfO-tNa7oYLtBZo7bBTI46Rov7u7fpYzJ7eXia3swSTSnwZElkLjkomXFhNNS6oJAvgVFKMmKA1ppJqTNa84I1QlAplG5EoTMAUwMQNkZXf73auxC8aare22HSvqKkOnxYHT6sqKg4Zz_EHGYv</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Proposal for the Best Pharmacovigilance Plan in Japan by comparing Japan Postmarketing Studies to the U.S. Postmarketing Requirements</title><source>J-STAGE Free</source><creator>KOKAN, Akira ; KAI, Yasuhiko ; KAGEYAMA, Shigeru ; KUBOTA, Kiyoshi ; TSUTANI, Kiichiro ; NISHI, Toshimichi ; MAEDA, Rei ; MASADA, Mikio ; MIYAKAWA, Kou</creator><creatorcontrib>KOKAN, Akira ; KAI, Yasuhiko ; KAGEYAMA, Shigeru ; KUBOTA, Kiyoshi ; TSUTANI, Kiichiro ; NISHI, Toshimichi ; MAEDA, Rei ; MASADA, Mikio ; MIYAKAWA, Kou</creatorcontrib><identifier>ISSN: 1342-0445</identifier><identifier>EISSN: 1882-790X</identifier><identifier>DOI: 10.3820/jjpe.17.55</identifier><language>eng</language><ispartof>Japanese journal of pharmacoepidemiology, 2012, Vol.17 (1), p.55-66</ispartof><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1125-d096952a9457ec2bc8126d2311040e21bc399c41b583f77197acf78c422eb2203</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids></links><search><creatorcontrib>KOKAN, Akira</creatorcontrib><creatorcontrib>KAI, Yasuhiko</creatorcontrib><creatorcontrib>KAGEYAMA, Shigeru</creatorcontrib><creatorcontrib>KUBOTA, Kiyoshi</creatorcontrib><creatorcontrib>TSUTANI, Kiichiro</creatorcontrib><creatorcontrib>NISHI, Toshimichi</creatorcontrib><creatorcontrib>MAEDA, Rei</creatorcontrib><creatorcontrib>MASADA, Mikio</creatorcontrib><creatorcontrib>MIYAKAWA, Kou</creatorcontrib><title>Proposal for the Best Pharmacovigilance Plan in Japan by comparing Japan Postmarketing Studies to the U.S. Postmarketing Requirements</title><title>Japanese journal of pharmacoepidemiology</title><issn>1342-0445</issn><issn>1882-790X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNpdkN1KwzAcxYMoOOZufIJcC63JP03TXOrwk4HFOfCupFm6Za5NTTJhD-B72-muvDo_DofD4SB0SUnKCiDXm01vUipSzk_QiBYFJEKS99OBWQYJyTJ-jiYh2JoQABA5oSP0XXrXu6C2uHEex7XBtyZEXK6Vb5V2X3Zlt6rTBpeDYNvhZ9UPUO-xdm2vvO1WR6t0IbbKf5h48OZxt7Qm4Oh-SxfpPP2XeDWfO-tNa7oYLtBZo7bBTI46Rov7u7fpYzJ7eXia3swSTSnwZElkLjkomXFhNNS6oJAvgVFKMmKA1ppJqTNa84I1QlAplG5EoTMAUwMQNkZXf73auxC8aare22HSvqKkOnxYHT6sqKg4Zz_EHGYv</recordid><startdate>2012</startdate><enddate>2012</enddate><creator>KOKAN, Akira</creator><creator>KAI, Yasuhiko</creator><creator>KAGEYAMA, Shigeru</creator><creator>KUBOTA, Kiyoshi</creator><creator>TSUTANI, Kiichiro</creator><creator>NISHI, Toshimichi</creator><creator>MAEDA, Rei</creator><creator>MASADA, Mikio</creator><creator>MIYAKAWA, Kou</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>2012</creationdate><title>Proposal for the Best Pharmacovigilance Plan in Japan by comparing Japan Postmarketing Studies to the U.S. Postmarketing Requirements</title><author>KOKAN, Akira ; KAI, Yasuhiko ; KAGEYAMA, Shigeru ; KUBOTA, Kiyoshi ; TSUTANI, Kiichiro ; NISHI, Toshimichi ; MAEDA, Rei ; MASADA, Mikio ; MIYAKAWA, Kou</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1125-d096952a9457ec2bc8126d2311040e21bc399c41b583f77197acf78c422eb2203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><toplevel>online_resources</toplevel><creatorcontrib>KOKAN, Akira</creatorcontrib><creatorcontrib>KAI, Yasuhiko</creatorcontrib><creatorcontrib>KAGEYAMA, Shigeru</creatorcontrib><creatorcontrib>KUBOTA, Kiyoshi</creatorcontrib><creatorcontrib>TSUTANI, Kiichiro</creatorcontrib><creatorcontrib>NISHI, Toshimichi</creatorcontrib><creatorcontrib>MAEDA, Rei</creatorcontrib><creatorcontrib>MASADA, Mikio</creatorcontrib><creatorcontrib>MIYAKAWA, Kou</creatorcontrib><collection>CrossRef</collection><jtitle>Japanese journal of pharmacoepidemiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KOKAN, Akira</au><au>KAI, Yasuhiko</au><au>KAGEYAMA, Shigeru</au><au>KUBOTA, Kiyoshi</au><au>TSUTANI, Kiichiro</au><au>NISHI, Toshimichi</au><au>MAEDA, Rei</au><au>MASADA, Mikio</au><au>MIYAKAWA, Kou</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Proposal for the Best Pharmacovigilance Plan in Japan by comparing Japan Postmarketing Studies to the U.S. Postmarketing Requirements</atitle><jtitle>Japanese journal of pharmacoepidemiology</jtitle><date>2012</date><risdate>2012</risdate><volume>17</volume><issue>1</issue><spage>55</spage><epage>66</epage><pages>55-66</pages><issn>1342-0445</issn><eissn>1882-790X</eissn><doi>10.3820/jjpe.17.55</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1342-0445
ispartof Japanese journal of pharmacoepidemiology, 2012, Vol.17 (1), p.55-66
issn 1342-0445
1882-790X
language eng
recordid cdi_crossref_primary_10_3820_jjpe_17_55
source J-STAGE Free
title Proposal for the Best Pharmacovigilance Plan in Japan by comparing Japan Postmarketing Studies to the U.S. Postmarketing Requirements
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T09%3A11%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Proposal%20for%20the%20Best%20Pharmacovigilance%20Plan%20in%20Japan%20by%20comparing%20Japan%20Postmarketing%20Studies%20to%20the%20U.S.%20Postmarketing%20Requirements&rft.jtitle=Japanese%20journal%20of%20pharmacoepidemiology&rft.au=KOKAN,%20Akira&rft.date=2012&rft.volume=17&rft.issue=1&rft.spage=55&rft.epage=66&rft.pages=55-66&rft.issn=1342-0445&rft.eissn=1882-790X&rft_id=info:doi/10.3820/jjpe.17.55&rft_dat=%3Ccrossref%3E10_3820_jjpe_17_55%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true